AEON Biopharma Inc. - Ordinary Shares - Class A
AEON
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.72M
Close$
$-5.54
1650.9% downside
Current Fair Value
1650.9% downsideOvervalued by 1650.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.72 Million |
|---|---|
| Enterprise Value | $2.10 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.95 |
| Beta | 0.61 |
| Outstanding Shares | 12,105,902 |
Return
| Return on Equity | 358.82% |
|---|---|
| Return on Assets | -696.52% |
| Return on Invested Capital | -963.23% |
Valuation & Multiples
| P/E Ratio | -0.1 |
|---|---|
| PEG | 0.04 |
| Price to Sales | - |
| Price to Book Ratio | -0.18 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.11 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.25 |
| Debt to Equity | -0.16 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 20, 2026
EPS Estimate
$-0.44
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.33
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 28.64%▲ 4.02% |
|---|---|
| Total Invested | $2.80M▲ 68.00% |
| Investors Holding | 24▲ 2.00% |
ESG Score
No data